000 01599 a2200481 4500
005 20250511200214.0
264 0 _c19910227
008 199102s 0 0 eng d
022 _a0022-5347
024 7 _a10.1016/s0022-5347(17)38316-7
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aVirag, R
245 0 0 _aIntracavernous self-injection of vasoactive drugs in the treatment of impotence: 8-year experience with 615 cases.
_h[electronic resource]
260 _bThe Journal of urology
_cFeb 1991
300 _a287-92; discussion 292-3 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdrenergic alpha-Antagonists
_xadministration & dosage
650 0 4 _aAtropine
650 0 4 _aConsumer Behavior
650 0 4 _aDipyridamole
650 0 4 _aDrug Combinations
650 0 4 _aDrug Therapy, Combination
650 0 4 _aErectile Dysfunction
_xdrug therapy
650 0 4 _aFollow-Up Studies
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPapaverine
_xadministration & dosage
650 0 4 _aPenile Erection
_xdrug effects
650 0 4 _aPenis
_xblood supply
650 0 4 _aPiperidines
650 0 4 _aPiribedil
650 0 4 _aRegional Blood Flow
650 0 4 _aSelf Administration
650 0 4 _aTime Factors
650 0 4 _aYohimbine
700 1 _aShoukry, K
700 1 _aFloresco, J
700 1 _aNollet, F
700 1 _aGreco, E
773 0 _tThe Journal of urology
_gvol. 145
_gno. 2
_gp. 287-92; discussion 292-3
856 4 0 _uhttps://doi.org/10.1016/s0022-5347(17)38316-7
_zAvailable from publisher's website
999 _c1677522
_d1677522